In a letter, the FDA stated that additional efficacy data are required to support an approval for chronic spontaneous urticaria (CSU), according to the manufacturers of dupilumab.
Rhinovirus infection is associated with stimulating histamine-releasing factor (HRF) and HRF-reactive immunoglobulin E for increasing severity of asthma and exacerbations.
Misinformation and disinformation about urticaria abound online, and doctors need to combat the false claims with facts, researchers in Ireland report.